What they were paid
Terns Pharmaceuticals Director Compensation Table · the one fiscal year held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2024 | $37,654 | $0 | $168,268 | — | $205,922 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Terns Pharmaceuticals, Inc. DEF 14A filed April 29, 2025, accession 0000950170-25-060138, and prior-year filings. Open the filing on EDGAR.
How this board is paid
company policy · FY2024Terns Pharmaceuticals pays directors a $40,000 cash retainer.
Committees
FY2024 · as the proxy prints themAudit · Research and Development (Chair)
The rest of the Terns Pharmaceuticals board
FY2024 · as the company reported each| Director | Role | FY2024 total |
|---|---|---|
| Amy Burroughs | Director | $0 |
| David Fellows | Chair of the Board | $234,829 |
| Heather Turner | Independent Director | $249,800 |
| Hongbo Lu | Independent Director | $197,966 |
| Jeffrey Kindler | Independent Director | $198,268 |
| Jill Quigley | Independent Director | $300,457 |
| Robert Azelby | Independent Director | $0 |
The full Terns Pharmaceuticals compensation record
free company briefThis page is one director within Terns Pharmaceuticals's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat